These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13573948)

  • 1. [Immuno-mechanisms after vaccination with inactivated poliomyelitis viruses and natural poliomyelitis infection].
    Dtsch Med Wochenschr; 1958 Aug; 83(35):1502-5. PubMed ID: 13573948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody formation after vaccination with inactivated poliomyelitis virus; results of a study of 40 children without demonstrable antibodies before vaccination].
    LENNARTZ H; HERTENSTEIN C; CRUSEMANN-HAKE R
    Dtsch Med Wochenschr; 1958 Feb; 83(8):286-8. PubMed ID: 13512066
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural infection with poliomyelitis viruses and other enteric viruses of man.
    GELFAND HM
    J La State Med Soc; 1957 Jul; 109(7):237-45. PubMed ID: 13439297
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of immunity in mice after vaccination with inactivated poliomyelitis virus.
    KRECH U
    J Immunol; 1955 Feb; 74(2):117-9. PubMed ID: 14354189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempted cross immunization of mice with poliomyelitis Lansing and Teschen disease viruses].
    LEGEZYNSKI S; SZAFLARSKI J
    Med Dosw Mikrobiol; 1954; 6(4):367-73. PubMed ID: 14355619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Present prospects of poliomyelitis vaccination with attenuated living viruses].
    LEPINE P; GOUBE DE LAFOREST P
    Presse Med (1893); 1957 Mar; 65(21):470-3. PubMed ID: 13431753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination against poliomyelitis with living avirulent viruses; preliminary report].
    BUSER F; SCHAR M
    Schweiz Med Wochenschr; 1958 Dec; 88(51):1282-4. PubMed ID: 13624659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Status of poliomyelitis epidemiology in Belgium after 3 years of vaccination with formolized virus].
    LAFONTAINE A; DE WEVER A
    Brux Med; 1961 Jul; 41():1067-79. PubMed ID: 13758197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natural immunity and vaccination against poliomyelitis].
    LEPINE P
    Presse Med (1893); 1957 Nov; 65(81):1818. PubMed ID: 13505604
    [No Abstract]   [Full Text] [Related]  

  • 10. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipoliomyelitis vaccination with live attenuated viruses].
    GAVRILA I; IURASOG G
    Microbiol Parazitol Epidemiol (Bucur); 1961; 6():103-10. PubMed ID: 13704044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with antipoliomyelitis vaccination with inactivated virus according to the Salk method in a preventorium community].
    GROSSO E; CAROLA H
    Boll Ist Sieroter Milan; 1960; 39():524-32. PubMed ID: 13709107
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of active immunogenesis in poliomyelitis. I. Persistence and recall by homotypic or heterotypic superinfection of neutralizing antibody originally induced in chimpanzees by vaccination or infection.
    HOWE HA
    Am J Hyg; 1954 Nov; 60(3):371. PubMed ID: 13207106
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is the status of antipoliomyelitis vaccination with attenuated live viruses?].
    RECHT P
    Brux Med; 1960 Oct; 40():1363-84. PubMed ID: 13740161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status of antipoliomyelitis vaccination with dead viruses (Salk vaccine)].
    MARQUEZ LA; POLACK NR
    Dia Med; 1959 Apr; 31(20):521-2. PubMed ID: 13663683
    [No Abstract]   [Full Text] [Related]  

  • 16. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity in poliomyelitis, with special reference to vaccination.
    SABIN AB
    Monogr Ser World Health Organ; 1955; 26():297-334. PubMed ID: 14374579
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complications after peroral poliomyelitis vaccination].
    WIESMANN E; WEGMANN T
    Schweiz Med Wochenschr; 1962 Mar; 92():367-70. PubMed ID: 14006854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with the before and after poliomyelitis vaccination in Langenlois, Lower Austria].
    AUERSWALD W; KOELBL H; STOITZNER-FIALA Y; GERHARDUS-CHIARI E; SEEBAUER F
    Wien Klin Wochenschr; 1960 Dec; 72():936-7. PubMed ID: 13685094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Typing of humoral antibodies before and after anti-poliomyelitis vaccination in the population of northern France].
    GERNEZ-RIEUX C; GERVOIS M
    Bull Acad Natl Med; 1958 Jun 3-10; 142(19-20):542-50. PubMed ID: 13560957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.